In the second study, the effects of TwX were examined in a mouse model of AD with chronic cerebral hypoperfusion (CCH + APP23 mice), with observed loss of hippocampal neurons and increased expression of oxidative stress markers, p-tau, and phospho-α-synuclein. This evidence concerns the gene MAPT and Alzheimer disease.